Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Use of a stable-isotope-labeled reporter peptide and antioxidants for reliable quantification of methionine oxidation in a monoclonal antibody by liquid chromatography/mass spectrometry.

Kang P, Mezhebovsky T, Chen W, McCardle JA, Zhang S, Sullivan EP, Sass PM, Routhier E.

Rapid Commun Mass Spectrom. 2016 Jul 30;30(14):1734-1742. doi: 10.1002/rcm.7646.

PMID:
28328036
2.

Variable-Temperature Tip-Enhanced Raman Spectroscopy of Single-Molecule Fluctuations and Dynamics.

Park KD, Muller EA, Kravtsov V, Sass PM, Dreyer J, Atkin JM, Raschke MB.

Nano Lett. 2016 Jan 13;16(1):479-87. doi: 10.1021/acs.nanolett.5b04135. Epub 2015 Dec 28.

PMID:
26679007
3.

Nanoscale probing of dynamics in local molecular environments.

Atkin JM, Sass PM, Teichen PE, Eaves JD, Raschke MB.

J Phys Chem Lett. 2015 Nov 19;6(22):4616-21. doi: 10.1021/acs.jpclett.5b02093. Epub 2015 Nov 9.

PMID:
26528865
4.

Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.

Drozdowski B, Zhou Y, Kline B, Spidel J, Chan YY, Albone E, Turchin H, Chao Q, Henry M, Balogach J, Routhier E, Bavari S, Nicolaides NC, Sass PM, Grasso L.

J Immune Based Ther Vaccines. 2010 Dec 21;8:9. doi: 10.1186/1476-8518-8-9.

5.

Advances in targeted therapeutic agents.

Nicolaides NC, Sass PM, Grasso L.

Expert Opin Drug Discov. 2010 Nov;5(11):1123-40. doi: 10.1517/17460441.2010.521496. Epub 2010 Oct 1. Review.

PMID:
22827748
6.

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Hassan R, Ebel W, Routhier EL, Patel R, Kline JB, Zhang J, Chao Q, Jacob S, Turchin H, Gibbs L, Phillips MD, Mudali S, Iacobuzio-Donahue C, Jaffee EM, Moreno M, Pastan I, Sass PM, Nicolaides NC, Grasso L.

Cancer Immun. 2007 Dec 19;7:20.

7.

Developing novel biopharmaceutical products through morphogenics.

Nicolaides NC, Sass PM, Chao Q, Kline JB, Ebel W, Routhier E, Zhou Y, Grasso L.

Expert Opin Drug Discov. 2007 Dec;2(12):1619-29. doi: 10.1517/17460441.2.12.1619.

PMID:
23488905
8.

Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.

Ebel W, Routhier EL, Foley B, Jacob S, McDonough JM, Patel RK, Turchin HA, Chao Q, Kline JB, Old LJ, Phillips MD, Nicolaides NC, Sass PM, Grasso L.

Cancer Immun. 2007 Mar 9;7:6.

9.

Rapid generation of plant traits via regulation of DNA mismatch repair.

Chao Q, Sullivan CD, Getz JM, Gleason KB, Sass PM, Nicolaides NC, Grasso L.

Plant Biotechnol J. 2005 Jul;3(4):399-407.

10.

Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.

Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, Jacob S, Kline B, Lazo E, Rotella F, Routhier E, Rudolph K, Sage J, Simon P, Yao J, Zhou Y, Kavuru M, Bonfield T, Thomassen MJ, Sass PM, Nicolaides NC, Grasso L.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3557-62. Epub 2006 Feb 27.

11.

Morphogenics as a tool for target discovery and drug development.

Nicolaides NC, Ebel W, Kline B, Chao Q, Routhier E, Sass PM, Grasso L.

Ann N Y Acad Sci. 2005 Nov;1059:86-96. Review.

PMID:
16382047
12.

Antimicrobial peptides: structure, function and therapeutic potential.

Sass PM.

Curr Opin Drug Discov Devel. 2000 Sep;3(5):646-54.

PMID:
19649893
13.

The involvement of selectins in cell adhesion, tumor progression, and metastasis.

Sass PM.

Cancer Invest. 1998;16(5):322-8. Review. No abstract available.

PMID:
9627680
14.

Engagement of the Lewis X antigen (CD15) results in monocyte activation.

Lo SK, Golenbock DT, Sass PM, Maskati A, Xu H, Silverstein RL.

Blood. 1997 Jan 1;89(1):307-14.

15.

Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell function.

Ho JL, Kim HK, Sass PM, He S, Geng J, Xu H, Zhu B, Turco SJ, Lo SK.

J Immunol. 1996 Oct 1;157(7):3013-20.

PMID:
8816410
16.

Isolation and characterization of mutants of human mitogen-activated protein kinase (ERK2).

Krishnan IS, Kovacs ED, Sass PM.

FEBS Lett. 1994 Oct 17;353(2):185-8.

17.

Post-translational processing of purified human K-ras in Xenopus oocytes.

Kaplan JB, Sass PM.

Cancer Commun. 1991;3(12):383-8.

PMID:
16296004
18.

Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin.

Ferguson-Chanowitz KM, Katocs AS Jr, Pickett WC, Kaplan JB, Sass PM, Oronsky AL, Kerwar SS.

J Infect Dis. 1990 Nov;162(5):1081-6.

PMID:
2230235

Supplemental Content

Support Center